09/06 .2021
Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing
Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing
11/03 .2021
BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia
BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia
11/18 .2021
China's BioKangtai Begins First Shipment of AstraZeneca's COVID-19 Shot
China's BioKangtai Begins First Shipment of AstraZeneca's COVID-19 Shot
11/19 .2021
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time
12/30 .2021
BioKangtai 30 Million Doses of Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported
BioKangtai 30 Million Doses of Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported
01/11 .2022
BioKangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Was Approved As Booster Dose in Indonesia
BioKangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Was Approved As Booster Dose in Indonesia